The Evidence Base® reposted this
Yesterday's announcement from CMS regarding the prices of drugs selected under the #InflationReductionAct has been the topic of much discussion over the past 24 hours. In my latest article on The Evidence Base®, I delve into the details of this announcement, exploring the ongoing debates around transparency and the potential impact on patient access, and highlighting what this could mean for the future of the biopharma sector. Read on The Evidence Base®: https://lnkd.in/eMGhVvtJ Kimberly Westrich Brian Reid John O'Brien Inmaculada (Inma) Hernandez Sean Sullivan